Tuesday | Wednesday | Wednesday (OnDemand) | Thursday | Friday

 

WEDNESDAY, DECEMBER 9, 2020 (OnDemand)
     
                            Prerecorded Sessions  

WILLIAM L. MCGUIRE MEMORIAL LECTURE supported by GlaxoSmithKline Oncology (GSK)
Mary-Claire King, PhD
University of Washington
Seattle, WA

AACR Distinguished Lectureship in Breast Cancer Research
 
     
  AACR Outstanding Investigator Award for Breast Cancer Research   
     
  Susan G. Komen ® Recognizes Renowned Investigators as the 2020 Recipients of Brinker Awards for Scientific Distinction   
  Brinker Award for Scientific Distinction in Basic Science
Donald P. McDonnell, PhD
Duke University School of Medicine
Durham, NC  
 
  Brinker Award for Scientific Distinction in Clinical Research
Laura Esserman, MD
University California San Francisco
San Francisco, CA 
 
     
     

PLENARY LECTURES

 
Presented by SABCS and SSO - Local Regional Management Following Neoadjuvant Therapy: Minding the Knowledge Gaps
 
                           Elizabeth A. Mittendorf, MD, PhD
Bringham and Women's Hospital
Dana-Farber Cancer Institute
Boston, MA
 
 
 

Advancing Cancer Research During Challenging Times

 
                           Norman E. "Ned" Sharpless, MD
National Cancer Institute
Bethesda, MD
 
 
  MINI-SYMPOSIA  

Recent Advances in Breast Cancer Prevention
Moderator: Katherine Crew, MD, MSc
Columbia University
New York, NY
 
 

Is it time to implement lifestyle interventions in the oncology clinic
Melinda Irwin, MD, MPH, PhD
Yale University
New Haven, CT

What else is in the imaging: How AI can improve mammograms?
Constance Lehman, MD, PhD
Massachusetts General Hospital
Boston, MA

Beyond hormones: Newer pharmacologic approaches
Powel Brown, MD, PhD
UT MD Anderson Cancer Center
Houston, TX

     
  Mechanisms of Mutagenesis in Breast Cancer
Moderator: Douglas Yee, MD
Masonic Cancer Center
University of Minnesota
Minneapolis, MN
 

Aging
Mike Stratton, FMedSci, FRS
Wellcome Sanger Institute
Hinxton, United Kingdom

BRCA/HRD
Andrew Tutt, MB CHB, PhD
Institute of Cancer Research
London, United Kingdom

APOBEC
Reuben Harris, PhD
Howard Hughes Medical Institute
University of Minnesota
Minneapolis, MN

 
 
 
  BASIC SCIENCE FORUM  

The Tumor and Immune Ecosystem of Breast Cancer
Moderator: Chonghui Cheng, MD, PhD
Baylor College of Medicine
Houston, TX

 
                          

Single-cell pathology landscape
Jennifer A. Wargo, MD, MMSc
UT MD Anderson Cancer Center
Houston, TX

Spatial variance signatures/Intra-tumor zonation in TNBC
Morag Park, PhD
Goodman Cancer Research Centre
Montreal, Canada

 
     
  CLINICAL SCIENCE FORUM  

Next Generation Sequencing in Clinical Practice
Moderator: Matthew J. Ellis, MB, BChir, BSc, PhD, FRCP
Baylor College of Medicine
Houston, TX
 
  Understanding current platforms
Mark E. Burkard, MD, PhD
University of Wisconsin-Madison
Madison, WI

Interpreting reports
Ben Ho Park, MD, PhD
Vanderbilt University Medical Center
Vanderbilt-Ingram Cancer Center
Nashville, TN
 
     
  TRANSLATIONAL SCIENCE FORUMS  

Antibody-Drug Conjugates, Better Together
Moderator: Mark Pegram, MD
Stanford University
Stanford Cancer Institute
Stanford, CA
 
                          

The making of an ADC
Paul Parren, PhD
Lava Therapeutics
Utrecht, Netherlands

What's available now and what's on the horizon (Early development)
Aditya Bardia, MBBS, MPH
Massachusetts General Hospital
Harvard Medical School
Boston, MA

 
     
  Mechanisms of Response to Immune Checkpoint Therapies
Moderator: Jeffrey Rosen, PhD
Baylor College of Medicine
Houston, TX
 
 

B-cells and follicular T cells regulate responses to immune checkpoint inhibitors in breast tumors and melanomas
Charles M. Perou, PhD
University of North Carolina
Chapel Hill, NC

Replication stress response defects predict responses to ICT in non-hypermutated tumors
Shiaw-Yih Lin, PhD
UT MD Anderson Cancer Center
Houston, TX

 
 

CLINICAL CASE DISCUSSIONS
Moderator: Mothaffar Rimawi, MD
Baylor College of Medicine
Houston, TX

Case Discussion 1 

Panel Members

Eric P. Winer, MD
Dan-Farber Cancer Center
Boston, MA

Roshni Rao, MD
Columbia University
New York, NY

Karla Sepulveda, MD
Baylor College of Medicine
Houston, TX

Sara Hurvitz, MD FACP
University of California Los Angeles
Los Angeles, CA

Charlotte Coles,
Cambridge University
Cambridge, United Kingdom

Case Discussion 2

Panel Members

Stephen Johnston
The Royal Marsden
London, United Kingdom

Lisa A. Carey, MD
University of North Carolina
Chapel Hill, NC

Swati Kulkarni, MD
Northwestern Medicine
Chicago, IL

Wendy A. Woodward, MD, PhD
 UT MD Anderson Cancer Center
Houston, TX

Andrea Richardson, MD, PhD
Johns Hopkins Medicine
Washington, DC)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
     

POSTERS  
 

 
 
Tuesday | Wednesday | Wednesday (OnDemand) | Thursday | Friday
 

S1-04.

S1-04.

Phase III study of trastuzumab emtansine (T-DM1) vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy including trastuzumab: primary results from KATHERINE
Limited to 200 participants; registrations will be accepted on a first-come, first-served basis and are free of charge. Badges are required and will be scanned at door for registration.   Attendees should prepare to visit 3-4 tables during the session. Attendees will be asked to rotate tables every 20 minutes.
Limited to 200 participants; registrations will be accepted on a first-come, first-served basis and are free of charge. Badges are required and will be scanned at door for registration.   Attendees should prepare to visit 3-4 tables during the session. Attendees will be asked to rotate tables every 20 minutes.
Limited to 200 participants; registrations will be accepted on a first-come, first-served basis and are free of charge. Badges are required and will be scanned at door for registration.   Attendees should prepare to visit 3-4 tables during the session. Attendees will be asked to rotate tables every 20 minutes.
In collaboration with  Astro     and     SSO